HGBL · Heritage Global Inc.
One customer — 78% of receivables (March 31, 2026)
“The Company's portfolio includes its largest borrower’s gross note receivable balance of approximately $21.4 million, representing 78% of our total gross notes receivable balance as of March 31, 2026, as compared to 76% as of December 31, 2025.”
One customer — 76% of receivables (December 31, 2025)
“The Company's portfolio includes its largest borrower’s gross note receivable balance of approximately $21.4 million, representing 78% of our total gross notes receivable balance as of March 31, 2026, as compared to 76% as of December 31, 2025.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-21 | Dove Nicholas Kirk |
President, Industrial Assets |
Buy↑
|
Common Stock
|
26,000 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Convert↓
Filing footnotes — Options to purchase common stock (Direct)
Options were granted 6/1/2019 and vested 25% annually beginning on the first anniversary of the grant date. |
Options to purchase common stock
|
31,875 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Tax↑
|
Common Stock
|
23,919 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Convert↑
|
Common Stock
|
31,875 |
| 2026-05-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-04-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-03-05 | Hexner Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Burnham William L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Sharpe Kelly S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | SHIMER SAMUEL L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Sinsley Barbara A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-02-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-01-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-12-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-11-03 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.41 to $1.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-10-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
7,468 |
| 2025-03-25 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
4,727 |
| 2025-03-25 | DOVE ROSS |
Director, CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
25,094 |
| 2025-03-25 | COBB BRIAN J. |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
6,408 |
| 2025-03-11 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
7,000 |
| 2025-03-06 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.03 to $2.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-03-06 | Burnham William L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | DOVE ROSS |
Director, CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
44,355 |
| 2025-03-06 | SHIMER SAMUEL L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | COBB BRIAN J. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
11,848 |
| 2025-03-06 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
11,848 |
| 2025-03-06 | Hexner Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | Sharpe Kelly S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | Sinsley Barbara A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-04 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-26 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-19 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-12 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-29 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.07 to $2.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-15 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-08 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-01 | COBB BRIAN J. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and vest 25% annually until December 31, 2028 |
Common Stock
|
125,000 |
| 2024-12-18 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-12-05 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-12-03 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-11-21 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-11-19 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The original Form 4, filed on November 20, 2024 (the "Original Filing"), is being amended by this Form 4 amendment (the "Amendment") solely to correct an administrative error which underreported the amount of securities beneficially owned by the reporting person following a sale transaction that occurred on November 19, 2024 by less than 1,825 shares. As a result of this administrative error, all Form 4s filed by the reporting person after the Original Filing underreported the amount of securities beneficially owned by the reporting person by 1,825 shares. This Amendment corrects the amount of securities beneficially owned by the reporting person in the Original Filing by increasing the amount by 1,825 shares. |
Common Stock
|
10,000 |
| 2024-03-20 | DOVE ROSS |
Director, CEO |
Buy↑
|
Common Stock
|
7,297 |
| 2024-03-19 | COBB BRIAN J. |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
13,638 |
| 2024-03-19 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Gloabl Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
11,830 |
| 2024-03-19 | Dove Nicholas Kirk |
President, Industrial Assets |
Buy↑
|
Common Stock
|
5,000 |
| 2024-03-07 | COBB BRIAN J. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 7, 2025. |
Common Stock
|
25,597 |
| 2024-03-07 | Sinsley Barbara A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 7, 2025. |
Common Stock
|
15,000 |
| 2024-03-07 | Burnham William L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 7, 2025. |
Common Stock
|
15,000 |